An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate

Abstract Background and Objectives The nucleoside reverse transcriptase inhibitors tenofovir alafenamide fumarate and tenofovir disoproxil fumarate are frequently employed in treating human immunodeficiency virus. Further, each form of tenofovir requires laboratory monitoring to determine efficacy a...

Full description

Saved in:
Bibliographic Details
Main Authors: Derek E. Murrell, Benjamin C. Kennard, Maria E. Bertoni, David B. Cluck, Jonathan P. Moorman, Stacy D. Brown, Kesheng Wang, Michelle M. Duffourc, Sam Harirforoosh
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-05-01
Series:Drugs in R&D
Online Access:https://doi.org/10.1007/s40268-025-00509-6
Tags: Add Tag
No Tags, Be the first to tag this record!